Syneron Medical and Procter & Gamble (P&G) have signed a joint development and supply agreement for the commercialization of patented, elos™ technology-based home-use devices for the skin for treating  fine lines, wrinkles, age and sun spots, and cellulite.

Under the terms of the agreement, Syneron will lead the research, development, and manufacturing of the products, while P&G will focus on developing the compositions, marketing, and distribution.

The home-use devices will be marketed under the P&G family of skin care products and will be cobranded with Syneron’s elos technology.

No launch date for the devices has been announced at this time. 

[Syneron, February 27, 2007]